Article

From ASCO: Updates in HER2-positive breast cancers

Author(s):

Debu Tripathy

Debu Tripathy blog image

Debu Tripathy, MD, editor-in-chief of CURE, discusses preliminary studies on combining Herceptin (trastuzumab) with existing drugs to treat HER2-positive breast cancer. These highlighted studies were presented at the 2013 American Society of Clinical Oncology's annual meeting in Chicago.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Immune Therapy Expands Melanoma Treatment to More Patients
Immune Therapy Expands Melanoma Treatment to More Patients
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
A Personalized Approach to Bladder Preservation in Urologic Cancers
image of doctor D'Sa
Mitigating Peripheral Neuropathy During Cancer Treatment
2 experts are featured in this series.
Exploring a Patient Case: Biomarker Testing After Progression and Discussing Treatment Choices With Your Care Team
2 experts are featured in this series.
Navigating Treatment After Progression: Testing, ESR1 Mutations and Tolerable Options
Image of Dr. Eng.
Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC
Image of Dr. Tagawa.
Breaking Down the Benefits of Clinical Trial Participation in Cancer Care
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Smoking Data May Guide Improved Lung Cancer Care and Patient Support
2 experts are featured in this series.
Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment
Illustration of doctor.
Breaking Down the Stigma and How to Better Understand Rare Blood Cancers
Related Content
Kim Johnson was diagnosed with stage 4 ovarian cancer in January 2016. Catch up on all of Kim's blogs here!
May 7th 2025

A Nurse Who Became Family After a Cancer Diagnosis

Kim Johnson
Eric Z. cared for my sister and mentored me with compassion, wisdom and unwavering presence — shaping my path in nursing and life.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
An Enhertu regimen significantly improved pathologic complete responses for high-risk HER2+ early-stage breast cancer: © karrastock - stock.adobe.com
May 7th 2025

Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer

Spencer Feldman
Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk HER2-positive early-stage breast cancer.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
ASHLEY TULLIO, B.S.N., RN
May 6th 2025

Fighting for Patients, Processes and Education

Dr. Theresa Medina
I would like to nominate Ashley Tullio, RN, for the Extraordinary Healer Award for Oncology Nursing.
Illustration of bladder.
May 6th 2025

The Importance of Personalized Treatment Approaches for Urologic Cancers

Ryan Scott
Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such as bladder or kidney cancer.